Drug Channels

JULY 12, 2022

Despite what you may have heard, pharmacy participation in the 340B Drug Pricing Program continues to thrive. Drug Channels Institute’s latest analysis reveals that an astonishing 32,000 pharmacy locations —more than half of the entire U.S. Is this really what Congress intended when the 340B program was established in 1992?

Pharmacy 98

Pharmacy Marketing Hospitals Drugs 98

Drug Channels

APRIL 12, 2023

In Drug Channels Institute’s list of the top 15 pharmacies of 2022 , we show that central-fill, mail pharmacies operated by large PBMs and health insurers have displaced retail chains as the largest prescription drug dispensers by revenues. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Independent Pharmacies Hospitals 98

Drug Channels

AUGUST 18, 2020

Hospitals and health systems are building a major presence in the specialty pharmacy industry. As we demonstrate below, nine out of ten large hospitals now operate a specialty pharmacy. Hospitals and other healthcare providers account for one-third of all U.S. accredited specialty pharmacies.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals Regulations 52

FDA Law Blog: Biosimilars

MAY 16, 2024

Houck — Employee diversion of controlled substances from hospitals has been an issue since at least 1986 when I became a diversion investigator with the Drug Enforcement Administration (“DEA”). The Kentucky hospital resolved the allegations for $4,394,600 and entered into a three-year MOA in November 2021.

Hospitals 59

Hospitals Nurses Compliance Pharmacy 59

FDA Law Blog: Biosimilars

MAY 30, 2024

The 340B statute requires drug manufacturers to sell certain drugs at discounted ceiling prices to covered entities, which are defined by statute to include certain types of safety net hospitals, health centers, and clinics receiving federal grants. A number of drug companies sued to enjoin enforcement.

Pharmacy 59

Pharmacy Pharmaceuticals Government Hospitals 59

Drug Channels

DECEMBER 5, 2023

Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription. The common factor behind these two disparate situations: Pharmaceutical wholesalers’ unusual pricing for brand-name drugs sold to pharmacies, hospitals, and other buyers. to 1:30 p.m.

Pharmacy 98

Pharmacy Drugs Hospitals Pharmaceuticals 98

Drug Channels

SEPTEMBER 21, 2022

In 2022, specialty pharmacies—via white, brown, and clear bagging—now constitute a meaningful share of the distribution channels for provider-administered oncology drugs. However, buy-and-bill appears to have rebounded substantially at hospitals. Read on for full details and the latest data.

Specialty Pharmacies 97

Specialty Pharmacies Hospitals Pharmacy Pharmaceuticals 97

Drug Channels

JULY 11, 2023

Looks like pharmacy and PBM profiteering within the 340B Drug Pricing Program will never go out of style. Drug Channels Institute’s (DCI) latest analysis reveals that more than 33,000 pharmacy locations —more than half of the entire U.S. Read on for my latest effort to pierce these little webs of 340B opacity.

Pharmacy 74

Pharmacy Marketing Hospitals Drugs 74

Drug Channels

JUNE 4, 2024

Meanwhile, employment and salaries in non-retail settings—hospitals, physician offices, outpatient centers, and home healthcare—continued to grow. What’s ahead for 340B-eligible hospitals? These settings now employ one in three U.S. pharmacists. Greener grass—or just different soil?

Hospitals 98

Hospitals Drugs Pharmacy 98

Drug Channels

MARCH 15, 2022

Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Pharmacies and Pharmacy Benefit Managers , our 13th edition, provides a comprehensive, fact-based, and non-partisan tool for understanding the entire U.S. I am pleased to announce our new 2022 Economic Report on U.S.

Pharmacy 98

Pharmacy Specialty Pharmacies Licensing Licensing 98

Drug Channels

OCTOBER 19, 2021

Hospitals and health systems are rapidly expanding their internal specialty pharmacies—and they’re using questionable tactics to boost revenues and profits. Nearly two-thirds of the larger health system specialty pharmacies operate as the exclusive pharmacy within self-insured health systems’ networks.

Specialty Pharmacies 96

Specialty Pharmacies Pharmacy Hospitals International 96

Drug Channels

JULY 23, 2020

The stunning growth of specialty pharmacies in the 340B Drug Pricing Program has accelerated a troubling trend: Patients covered by commercial insurance and Medicare Part D are footing the bill for 340B savings. Our indisputable math exposes the little-understood economics behind specialty pharmacies in the 340B program.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Drugs 52

Drug Channels

OCTOBER 12, 2021

specialty pharmacies—via white, brown, and clear bagging—continue to displace buy-and-bill distribution channels for provider-administered oncology drugs. The battle for the specialty patient pits hospitals against insurers—and their respective specialty pharmacies. Hospitals, however, lose profits and face higher costs.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Hospitals Pharmaceuticals 97

Drug Channels

JUNE 21, 2022

National Association of Specialty Pharmacy (NASP) 2022 Annual Meeting & Expo. The National Association of Specialty Pharmacy (NASP) will host the NASP 2022 Annual Meeting & Expo September 19-22. September 19-22, 2022 | Gaylord Palms Resort & Convention Center | Orlando, FL. www.naspnet.org/annualmeeting.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Nurses Hospitals 98

Drug Channels

SEPTEMBER 13, 2022

These include disruption to the now-booming biosimilar market, the prospects of physician/hospital vertical integration that will raise commercial healthcare costs and expand 340B, and the need for complex new processes to administer the IRA's lower pharmacy reimbursements.

Biosimilars 97

Biosimilars Pharmacy Hospitals Marketing 97

Drug Channels

DECEMBER 12, 2022

These include disruption to the now-booming biosimilar market, the prospects of physician/hospital vertical integration that will raise commercial healthcare costs and expand 340B, and the need for complex new processes to administer the IRA's lower pharmacy reimbursements.

Biosimilars 98

Biosimilars Pharmacy Hospitals Marketing 98

Drug Channels

MARCH 25, 2024

P.S. Join my nearly 54,000 LinkedIn followers for daily links to neat stuff.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Hospitals Drugs 97

Drug Channels

JANUARY 30, 2024

Plus, Dr. Glaucomflecken peeks inside a hospital owned by a private equity firm. Senator Cassidy tries to tackle CVS and Walgreens—and I give you a peek at a Walgreens 340B contract Offsides : To Gen Z, being a pharmacist is cheugy. P.S. A big THANK YOU for all the warm wishes and congratulations on DCI’s acquisition by HMP!

Hospitals 98

Hospitals Pharmacy Drugs Production 98

Drug Channels

MARCH 14, 2022

Asembia’s Specialty Pharmacy Summit 2022. Asembia's Specialty Pharmacy Summit 2022 is back! This is a must-attend event for anyone connected to specialty pharmacy. Plus, Doug Long from IQVIA and I will again lead the Featured Session, titled The Specialty Pharmacy Industry Update and Outlook. Gottlieb’s excellent book.

Specialty Pharmacies 74

Specialty Pharmacies Pharmacy FDA Science 74

Drug Channels

JUNE 15, 2021

Drug Channels Institute’s latest review of contract pharmacies in the 340B Drug Pricing Program reveals that an astonishing 30,000 pharmacy locations—half of the entire U.S. pharmacy industry—now act as contract pharmacies for the hospitals and other healthcare providers that participate in the 340B program.

Pharmacy 52

Pharmacy Hospitals Drugs 52

FDA Law Blog: Biosimilars

SEPTEMBER 12, 2023

More than 40 registrants — primarily hospitals and pharmacies — have paid significant civil penalties of up to $5,000,000 to settle allegations they failed to report controlled substance thefts or significant losses to the Drug Enforcement Administration (DEA). The risks to hospitals and pharmacies are multi-faceted and growing.

Hospitals 49

Hospitals Pharmacy Compliance Government 49

FDA Law Blog: Biosimilars

SEPTEMBER 26, 2023

More than 40 registrants — primarily hospitals and pharmacies — have paid significant civil penalties of up to $5,000,000 to settle allegations they failed to report controlled substance thefts or significant losses to the Drug Enforcement Administration (DEA). The risks to hospitals and pharmacies are multi-faceted and growing.

Hospitals 45

Hospitals Pharmacy Compliance Government 45

Drug Channels

MAY 17, 2022

Two weeks ago, Paula and I had the pleasure of attending Asembia’s 2022 Specialty Pharmacy Summit at the wonderful Wynn Las Vegas. Below, I violate Vegas code and tell you what happened there.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Drugs Hospitals 98

Drug Channels

MAY 18, 2021

specialty pharmacies. As you will note below, the specialty pharmacy industry remains quite diverse— despite the concentration of dispensing revenues within a small number of companies. It’s time for Drug Channels Institute’s annual update of the number of U.S. Fortunately, I had outstanding research assistance. See photo at right.).

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Hospitals 52

Drug Channels

SEPTEMBER 28, 2021

Curl up with your favorite pumpkin-spiced blog and savor these stories harvested from the Drug Channels patch: Fresh insights about hospitals’ specialty drug profits SSR Update: Drug prices keep dropping My $0.02 Autumn is here! You can also find me on LinkedIn , where I have more than 20,000 followers. d/b/a Drug Channels Institute.

Hospitals 81

Hospitals Biosimilars Pharmacy International 81

Drug Channels

OCTOBER 27, 2021

Scream as Blue Cross Blue Shield frightfully overpays hospitals Shocking! PBMs are conjuring a terrifying number of formulary exclusions for oncology drugs Eerie! Brrr.did you hear that? It’s the biosimilar boom! Believe it or not, U.S You can also find my daily posts on LinkedIn , where I have more than 20,000 followers.

Biosimilars 97

Biosimilars Hospitals Independent Pharmacies Pharmacy 97

Drug Channels

SEPTEMBER 23, 2020

Will COVID-19 trigger long-term share gains for specialty pharmacies as suppliers to hospitals and physician offices? Before the pandemic, specialty pharmacies—via white, brown, and clear bagging—had already displaced buy-and-bill distribution channels for a substantial chunk of provider-administered specialty drugs.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals Production 52

Drug Channels

DECEMBER 18, 2020

Will COVID-19 trigger long-term share gains for specialty pharmacies as suppliers to hospitals and physician offices? Before the pandemic, specialty pharmacies—via white, brown, and clear bagging—had already displaced buy-and-bill distribution channels for a substantial chunk of provider-administered specialty drugs.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals Production 52

Drug Channels

MAY 30, 2023

P.S. Join my more than 41,000 LinkedIn followers for daily links to neat stuff.

Biosimilars 98

Biosimilars Hospitals Pharmacy Drugs 98

Drug Channels

JULY 14, 2020

It’s time for our annual look at the 340B Drug Pricing Program’s booming pharmacy component. Our exclusive analysis of government data finds that 28,000 pharmacy locations—almost half of the U.S. industry—now act as contract pharmacies for the hospitals and other healthcare providers that participate in the 340B program.

Pharmacy 52

Pharmacy Government Hospitals Drugs 52

Drug Channels

JULY 21, 2020

pharmacies now participate in the 340B Drug Pricing Program. Below, we update our exclusive analysis of the biggest specialty pharmacies within 340B. The four largest specialty pharmacies are owned by CVS Health, Cigna’s Express Scripts business, UnitedHealth Group’s OptumRx business, and Walgreens Boots Alliance/Prime Therapeutics.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals Drugs 52

Drug Channels

JUNE 27, 2021

As you declare your vaccinated independence, celebrate with these Drug Channels fireworks: Amazon’s teeny step toward pharmacy disruption How patients view copay accumulators My $0.02 on generic and biosimilar trends Some hospitals seem to be gaming their 340B eligibility Plus, tips on effective hospital marketing.

Biosimilars 52

Biosimilars Hospitals Pharmacy Vaccine 52

Drug Channels

SEPTEMBER 2, 2020

I'm rerunning this post to provide context for manufacturers' recent actions regarding 340B contract pharmacies. Yesterday, Eli Lilly announced that its products can be dispensed only at covered entities and their child sites, but not via external pharmacies. per 3 mL pen or $0.10 per 10 mL vial.

Pharmacy 52

Pharmacy Government Hospitals Pharmaceuticals 52

Drug Channels

FEBRUARY 23, 2021

In this issue: Payers confess: Patients lose from copay accumulators Humana joins the Express Scripts GPO Hospitals vs. PBMs over specialty pharmacy white bagging Let’s all follow the Buy-and-Bill Dollar! Plus, entrepreneurial pharmacy owner Dave Marley demonstrates the power of innovation. See page 15 (reproduced below).

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Independent Pharmacies 52

Drug Channels

JUNE 7, 2021

National Association of Specialty Pharmacy (NASP) 2021 Annual Meeting & Expo. The National Association of Specialty Pharmacy (NASP) returns to Washington, D.C. on September 27-30 for the National Association of Specialty Pharmacy (NASP) 2021 Annual Meeting & Expo. Early Bird Registration Discount Ends June 30.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals Drugs 52

The Pharma Data

DECEMBER 17, 2020

Bernard Hospital today took delivery of the first batch of the Pfizer vaccine for the coronavirus, and Dr. Jennifer Atomah , director of the hospital’s pharmacy, placed the medicine in one of the ultra-cold freezers that allow that product to be stored for up to six months. Bernard Hospital. CHICAGO , Dec.

Hospitals 52

Hospitals Vaccine Pharmacy Production 52

Drug Channels

JUNE 3, 2020

Consistent with our previous analyses, the share of pharmacists who work at hospitals reached a new high. The challenges facing the retail pharmacy industry, which I discuss in this video , are now showing up in the employment data. Total pharmacist employment grew in 2019.

Hospitals 52

Hospitals Marketing Pharmacy Drugs 52